Can diphenoxylate/atropine (Lomotil) increase blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Lomotil Increase Blood Pressure?

Yes, Lomotil (diphenoxylate-atropine) can cause hypertension, particularly through its atropine component when used with MAO inhibitors or in overdose situations, though this is not a common effect at therapeutic doses.

Mechanism and Clinical Context

The hypertensive risk with Lomotil stems primarily from two sources:

Drug Interaction with MAO Inhibitors

The FDA label explicitly warns that diphenoxylate may interact with monoamine oxidase inhibitors (MAOIs) and precipitate a hypertensive crisis 1. The label specifically instructs to avoid use of Lomotil in patients taking MAOIs and to monitor for signs and symptoms of hypertensive crisis including headache, hyperthermia, and hypertension 1. This interaction is theoretically based on diphenoxylate's structural similarity to meperidine hydrochloride 1.

Atropine-Related Hypertension

The atropine component can cause anticholinergic effects including tachycardia and hypertension, particularly in:

  • Overdose situations: The FDA label notes that atropinism includes tachycardia, hyperthermia, flushing, and other anticholinergic symptoms 1
  • Pediatric patients: Especially those with Down's syndrome who are more susceptible to atropinism 1
  • Rare idiosyncratic reactions: A 2024 case report documented a hypertensive emergency (blood pressure reaching 294/121 mmHg) following atropine administration, though this was with standalone atropine rather than Lomotil 2

Clinical Presentation Patterns

In overdose cases, the clinical picture is complex:

  • Opioid effects predominate in 92% of cases (CNS and respiratory depression with miosis) 3
  • Atropine toxicity occurs in only 17% of cases (6 of 36 children), presenting with CNS excitement, hypertension, fever, and flushed dry skin 3
  • Timing is variable: Contrary to popular belief, atropine effects can occur before, during, or after opioid effects 3

Important Clinical Caveats

At therapeutic doses in patients not taking MAOIs, hypertension is not a typical adverse effect of Lomotil. The primary concerns are:

  • Respiratory and CNS depression (especially in children)
  • Anticholinergic symptoms (dry mouth, tachycardia, urinary retention)
  • Drug interactions with CNS depressants and alcohol 1

If a patient on Lomotil develops hypertension, consider:

  1. Concurrent MAOI use (absolute contraindication)
  2. Possible overdose (intentional or accidental)
  3. Other causes of hypertension unrelated to Lomotil

The hypertensive guidelines provided 4, 5 do not list Lomotil as a medication that commonly causes or exacerbates hypertension in routine clinical practice.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.